BENdamustine at Elevated Dose for Relapsed Follicular Lymphoma in Intensification Therapy and Transplantation (BENEFIT)
NCT02008006
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
21
Enrollment
OTHER
Sponsor class
Stopped
Insufficient recruitment and unavailability of the treatment
Conditions
Follicular Lymphoma
Interventions
DRUG:
BeEAM
Sponsor
Centre Leon Berard